Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases
US-12570662-B2 · Mar 10, 2026 · US
Nurix Therapeutics Inc holds 12 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 12 |
| Recent patents | 9 |
| First publication | Nov 18, 2021 |
| Latest publication | Mar 10, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12570662-B2 · Mar 10, 2026 · US
US-12528814-B2 · Jan 20, 2026 · US
US-2024417402-A1 · Dec 19, 2024 · US
US-2024400587-A1 · Dec 5, 2024 · US
US-12091426-B2 · Sep 17, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12570662-B2 · Mar 10, 2026 · US
US-12528814-B2 · Jan 20, 2026 · US
US-2024417402-A1 · Dec 19, 2024 · US
US-2024400587-A1 · Dec 5, 2024 · US
US-12091426-B2 · Sep 17, 2024 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 12 |
| Chemistry & Metallurgy | 12 |
| Cross-Sectional Technologies | 4 |
Answers are generated from the same data shown on this page.